N/A
N=27
Functionality of the Pulse Oximeter and Accelerometer Portions of a Novel Wearable Device
Hypoxic Events
Bottom Line
View on ClinicalTrials.gov: NCT05197790 ↗Enrolled (actual)
27
Serious AEs
0.0%
Results posted
Mar 2026
Primary outcome: Primary: Mean Absolute Error of Dove Device Compared to FDA Approved SpO2 Sensor — 0.45 percentage points
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- FDA approved pulse oximeter and DOVE device prototype (Device)
- Age
- Adult, Older Adult · 21+ yrs
- Sex
- All
- Sponsor
- University of Pennsylvania
- Primary completion
- Dec 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Absolute Error of Dove Device Compared to FDA Approved SpO2 Sensor |
0.45 | — |
| SECONDARY Questionnaire About Comfort of Device |
4.5 | — |
Summary
The purpose of this study is to asses the function of an oxygen sensor and the movement sensor in a novel device prototype.
Eligibility Criteria
Inclusion Criteria
- Males and Females
- 21 years of age or older
- Suspected to suffer from hypoxic events
- Able to provide informed consent
Exclusion Criteria
- Pregnant
Data sourced from ClinicalTrials.gov (NCT05197790). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.